Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Pre-Tax Income of $-78.59M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$21.19M |
|
$-79.12M |
|
$28.64M |
|
$-7.45M |
|
$92.81M |
|
$-71.62M |
|
$-6.96M |
|
|
Pre-Tax Income |
$-78.59M |
$-78.59M |
|
$-79.12M |
|
$-79.12M |
|
$-79.12M |
|
$-79.12M |
|
$-71.62M |
|
$-69.08M |
|
266.14M |
|
266.14M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$514.58M |
|
$66.85M |
|
$147.37M |
|
$661.95M |
|
$83.07M |
|
-- |
|
$313.42M |
|
$396.50M |
|
$265.45M |
|
$245.17M |
|
$265.45M |
|
266.14M |
|
| Cash Flow Statement Financials | |
$-216.25M |
|
$71.92M |
|
$-2.54M |
|
$228.80M |
|
$87.62M |
|
$-141.18M |
|
$10.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.15% |
|
-337.93% |
|
-337.93% |
|
-- |
|
-370.79% |
|
-373.30% |
|
$-236.17M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.03 |
|
0.65 |
|
138.45 |
|
-29.80% |
|
-32.27% |
|
-11.95% |
|
-29.80% |
|
$1.00 |
|
$-0.89 |
|
$-0.81 |
|